logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Ym Biosciences Australia Pty Ltd.

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 5.6



Forward Citations = 171

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Christopher John Burns (16 out of 26 patents)

silverMedal Andrew Frederick Wilks (10 out of 34 patents)

bronzeMedal John Thomas Feutrill (6 out of 12 patents)

4.  Michael Francis Harte (6 out of 7 patents)

5.  Harrison Sikanyika (5 out of 5 patents)

6.  Emmanuelle Fantino (5 out of 6 patents)

7.  Marcel Robert Kling (5 out of 5 patents)

8.  Jun Zeng (4 out of 7 patents)

9.  David Gerard Bourke (4 out of 5 patents)

10.  Anthony Nicholas Cuzzupe (4 out of 5 patents)

11.  Xianyong Bu (4 out of 9 patents)

12.  Tracy Leah Nero (4 out of 5 patents)

13.  Andrew Craig Donohue (2 out of 13 patents)

14.  Thao Lien Thi Nguyen (2 out of 3 patents)

15.  Lawrence S Zisman (1 out of 9 patents)


18 patents:

1. 9732046 - Substituted 1,2,4-triazines as tubulin inhibitors (2017-08-15),
2. 9499560 - N-containing heterocyclic compounds (2016-11-22),
3. 9233934 - Phenyl amino pyrimidine compounds and uses thereof (2016-01-12),
4. 9139560 - Substituted pyrazines as tubulin inhibitors (2015-09-22),
5. 9040549 - Thiopyrimidine-based compounds and uses thereof (2015-05-26),
6. 8809359 - Phenyl amino pyrimidine bicyclic compounds and uses thereof (2014-08-19),
7. 8765755 - N-containing heterocyclic compounds (2014-07-01),
8. 8486941 - Phenyl amino pyrimidine compounds and uses thereof (2013-07-16),
9. 8461161 - Substituted pyrazines as inhibitors of kinase activity (2013-06-11),
10. 8410173 - Inhibition of JAK2 as a treatment of pulmonary arterial hypertension (2013-04-02),
11. 8394806 - 2-phenyl pyrazines as tubulin inhibitors (2013-03-12),
12. 8354408 - N-containing heterocyclic compounds (2013-01-15),
13. 8329737 - Benzimidazoles as selective kinase inhibitors (2012-12-11),
14. 8084456 - Pyrazine-based tubulin inhibitors (2011-12-27),
15. 8030336 - Nicotinamide-based kinase inhibitors (2011-10-04),
Company Overview
Ym Biosciences Australia Pty Ltd is a biotechnology company focused on the development of innovative therapies for cancer treatment. The organization specializes in the research and advancement of novel drug candidates, leveraging cutting-edge technologies to address unmet medical needs in oncology. With a commitment to scientific excellence, Ym Biosciences aims to enhance patient outcomes through targeted therapies, contributing to the global fight against cancer. The company operates within a dynamic landscape of biopharmaceutical innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#23 in Foster City, CA

#4,295 in California

#17,980 in US

#34,263 in the World

Foster City, CA (US)
Foster City, CA, United States of America

Ym Biosciences Australia Pty Ltd.

Forward Citations = 171

21 inventors:

goldMedal Christopher John Burns (16 out of 26 patents)

silverMedal Andrew Frederick Wilks (10 out of 34 patents)

bronzeMedal John Thomas Feutrill (6 out of 12 patents)

4.  Michael Francis Harte (6 out of 7 patents)

5.  Harrison Sikanyika (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ym Biosciences Australia Pty Ltd.. Retrieved from https://idiyas.com/company/ym-biosciences-australia-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…